New Zealand - English - Medsafe (Medicines Safety Authority)

allergan new zealand ltd - dipivefrine hydrochloride 1 mg/ml (5% overage added) - eye drops, solution - 0.1 % - active: dipivefrine hydrochloride 1 mg/ml (5% overage added) excipient: benzalkonium chloride disodium edetate dihydrate hydrochloric acid purified water sodium chloride

New Zealand - English - Medsafe (Medicines Safety Authority)

allergan new zealand ltd - dipivefrine hydrochloride 1 mg/ml (5% overage added) - eye drops, solution - 0.1 % - active: dipivefrine hydrochloride 1 mg/ml (5% overage added) excipient: benzalkonium chloride disodium edetate dihydrate hydrochloric acid purified water sodium chloride

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; sodium chloride; benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; water for injections; dibasic sodium phosphate - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are intolerant or insufficiently responsive to another intraocular pressure lowering medication. indications as at 4 february 2003: reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - latanoprost 50 µg/ml;  ;   - eye drops, solution - 50 mcg/ml - active: latanoprost 50 µg/ml     excipient: benzalkonium chloride dibasic sodium phosphate monobasic sodium phosphate monohydrate sodium chloride water for injection - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: sodium chloride; dibasic sodium phosphate; benzalkonium chloride; water for injections; monobasic sodium phosphate monohydrate - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - latanoprost -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; benzalkonium chloride; sodium chloride; monobasic sodium phosphate monohydrate; water for injections - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

New Zealand - English - Medsafe (Medicines Safety Authority)

upjohn new zealand ulc - latanoprost 50 µg/ml;  ;  ;   - eye drops, solution - 50 mcg/ml - active: latanoprost 50 µg/ml       excipient: benzalkonium chloride dibasic sodium phosphate monobasic sodium phosphate monohydrate sodium chloride water for injection - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - latanoprost -